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ABSTRACT
GERD is a condition that gastric content go back into the esophagus. This condition could came distur-
bances in the respiratory tract, heart and otolaryng. Those extra-esophageal clinical manifestation are
common but often miss our attention. So it is important to explorate it further. The management of extra-
esophageal GERD is similar with management of GERD. It is included life style modification and reducing
refluxate with controlling pH with aggressiveness.
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INTRODUCTION
Wright, et al, evaluated 30 non-smoking asthmatic
patients with symptoms of gastroesophageal reflus dis-
ease (GERD) confirmed by pH-Metry, the effect of 20-
60 mg of omeprazole, 20 (67%) of which with improved
asthmatic symptoms, and 6 (20%) with increased Peak
Flow Rate (PFR).1
From the questionnaires distributed to 109 Canadi-
ans with asthma divided into 2 groups: the study subject
and control group. In the study subjects with the follow-
ing symptoms reported: 77% with heartburn, 55% with
regurgitation, and 24% with dysphagia, the incidence of
asthmatic attacks were more significant than in control
subjects.2 Since 1986, there have been many reported
studies on the relationship between esophagus and non-
cardiac chest pain. The relationship varies according to
the study subject and diagnostic criteria. In 27 out of 30
patients (90%), chest pain did not indicate signs of is-
chemia.3
Extra-esophageal clinical manifestation of GERD are
common, but often miss our attention. Thus it is impor-
tant to analyze it further. This paper will discuss the
anatomy, pathophysiology, clinical manifestation and man-
agement.
ANATOMY AND HISTOLOGY
A physician who intends to diagnose and manage
esphageal disorder should have knowledge of normal
esophageal anatomy, pathologic changes during initial
stages and optimal evaluation of each method for the
evaluation of esophageal function and morphology.4
The adult esophagus is a flat muscular cylinder from
the pharyngoesophageal junction (5th-6th cervical verte-
brae) through the back of the mediastinum, ending on
the gastroesophageal junction (first thoracal vertebrae).
The esophageal cavity could distend as much as 2 cm to
the front and back, and 3 cm to its sides. The length of
the adult esophagus varies from 18 to 26 cm. The esopha-
gus at the cervical region, from the pharyngoesophageal
junction to the suprasternal point is approximately 4-5
cm. At this level, the esophagus is bordered by the front
of the trachea, the vertebrae and the carotis and thyroid
membranes at each side.5
The thoracal portion of the esophagus passes through
the back to the tracheal wall and the back branch of the
right aorta (Thoracal 4), and then to the branches of the
trachea and the main bronchus, crossing the front of the
aorta at the diaphragmatic hiatus. At the level of the 10th
thoracal vertebrae, where the esophagus passes an open
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space shaped like an ellipse on the diaphragmatic muscle
and into the cardia of the gaster at an oblique angle.
At the level of the diaphragm, the esophagus is sur-
rounded by elastic collagen fibers from the
phrenoesophageal membrane.
BLOOD FLOW6
The arterial blood flow to the esophagus is an exten-
sive and overlapping segmental flow. The cervical por-
tion receives its blood flow mainly from the inferior branch
of the thyroid artery. Additional arterial branches are
the carotid, vertebral, subclavic and ascending pharyn-
geal arteries.
The thoracal portion of the esophagus receives its
blood flow from the right intercostal and the bronchial
branches of the aorta. The abdominal portion of the
esophagus receives its blood flow from branches of the
left gangster and the lower left pricnicus artery.
We have adequate knowledge of the anatomy of the
esophageal vein. The intraepithelial flow is collected into
the sub-epithelial superficial venous plexus. This plexus
flows into the intrinsic vein in the sub-mucosa.
INNERVATION
The vagal nerve only innervates the esophagus
parasymphatetically, even though it brings a collection
of sympathetic and parasympathetic fibers to the neck.
The cervical portion of the esophagus is innervated from
the recurrent laryngeal nerve innervate the upper tho-
racic esophagus. The left and right vagal nerves merge
with sympathetic fibers to form the esophageal plexus.7
As they leave the esophageal plexus, the anterior and
posterior vagal pathways separate. Below the diaphragm,
the anterior vagal pathway branches into the hepatic and
the anterior gastric branches. The posterior vagal path-
way branches to the celiac plexus and the posterior
gaster.
The esophageal wall consist of 4 layers:  (1) the mu-
cosa membrane, the tunica mucosa, (2) sub-mucosa or
tunica sub-mucosa, (3) external muscle or tunica mus-
cularis, (4) tunica adventia.
The inner most layer of the mucosal membrane is
made up of non-keratinizing squamous epithelium, which
supports the lamina propria tissue and the smooth muscle
layer. The squamous epithelium is made up of basal cells
as the basal stratum, the prichle cells known as the in-
termediate stratum and the superficial layer or the su-
perficial stratum.
PATHOPHYSIOLOGY
GERD could cause disturbances in the respiratory
tract, heart and otolaryng through 2 chief mechanisms,
as follows:
1. Gastropharingeal reflux, with or without small aspi-
rations from the gastric reflux matter causing an in-
flammatory reaction, known as the Crausaz reflux
theory.9
The gastroesophageal reflux can usually be pre-
vented by adequately functioning upper and lower
esophageal sphincter. Even though gastric juices of-
ten passes through the lower esophageal sphincter,
the basal pressure of the esophageal sphincter in-
creases if the reflux causes increased pressure from
the esophagus, followed by a reflex to close from
the esophagoglotic to protect the respiratory tract
from contact with reflux material. Swallowing or
coughing could clear the reflux on the upper esoph-
ageal sphincter.
2. Stimulation of esophagopulmonary or
esophagolaryngeal reflex, where reflux from the dis-
tal esophagus stimulate vagal reflex, causing
bronchoconstriction. This theory is called the reflex
theory.10 Other mechanisms that play a role is the
esophagobronchial reflex, an embryonic-derived por-
tion of the common innervation. Other physiologic
protection mechanisms prevent the reflux fluid from
entering the larynx-pharynx space. This repellant and
protective mechanism could mimic extra-esophageal
symptoms found in GERD.Figure 1. Esophageal innervation
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Anterior
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Anterior vagel
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The acidity of the lower esophagus could stimulate
sensitive acid receptors, which would then interact with
the vagal nerve on the upper respiratory tract. Adminis-
tration of 0.1 N HCl into the esophagus demonstrates
reduces respiratory flow.
In the mean time, very little is known about the affer-
ent sensory mechanism in humans, which could cause
chest pain, cough and asthma.11
This theory is supported by studies that demonstates
that small amounts of acid administered into the respira-
tory tract could cause bronchial spasm.
According to Gostal, acid reflux into the distal esopha-
gus is commonly found in patients with asthma and chronic
cough, but exposure on the proximal esophagus is rarely
found, which supports the concept that acid exposure on
the distal esophagus could cause the bronchial spasm
reflex, while acid exposure on the proximal esophagus
could cause chest pain.12
CLINICAL FINDINGS
Non-cardiac chest pain
Discomfort on the front chest is a fundamental part
of the esophageal chest pain syndrome. The pain is illus-
trated as a burning sensation, located at the back of the
chest, spreading to the back, neck, jaws, or arms, some-
times causing wind-like pain. The pain is usually uncon-
nected with swallowing activities, but may be induced
by cold or hot fluids. The pain usually wakens the pa-
tient from his or her sleep and gets worse if the patient is
emotionally disturbed.11 Patients with esophageal chest
pain usually complain of other esophageal symptoms.
For example, out of 100 patients, 74% suffered from
pyrosis, 67% from regurgitation, 49% dysphagia, and
14% odinophagia, while 11% did not demonstate esoph-
ageal symptoms.
Esophageal chest pain usually occur due to stimula-
tion on chemical receptors (acid, pepsin, bile acid), me-
chanic receptors (distention, spasm), or thermal recep-
tors (cold).
Long-term monitoring studies on the esophagus dem-
onstrate that GERD is a direct cause of non-cardiac chest
pain. In the year 1982, De Meester found a number of
GERD patients from 24-hour esophageal monitoring.
Twenty-three (46%) of 50 patients with angina-like chest
pain were found with normal coronary angiograms.14
DeCaestecker found abnormal reflux in 14 (28%) out of
50 patients with chest pain of unknown origin. 15
Schofield identified acid reflux in 23 (44%) out of 52
patients with chest pain and normal coronary angiogram,
but demonstrated reflux symptoms during treadmill test.16
Chest pain due to reflux could also occur in patients
with coronary arterial disorder, which is difficult to diag-
nose. Out of 30 patients, 20 67 were found with chest
pain accompanying acid reflux during long-term esoph-
ageal pH monitoring. Four patients also suffered from
ischemia, 2 of which caused by acid and 1 with reflux.17
It has been known that the differential diagnosis of chest
pain is hard to determine. The unique symptom of an-
gina pectoris may also be found in patients with chest
pain due to esophageal disorders. This could be explained
by the fact that the heart and esophagus has the same
innervation.18
The diagnosis of GERD as a cause of non-cardiac
chest pain is based on findings of esophagitis on endos-
copy or pathological reflux on 24-hour esophageal pH
monitoring. However, sometimes patients with esoph-
agitis cannot be detected using endoscopy. Endoscopy
has a sensitivity rate of approximately 50%, while 24-
hour esophageal pH monitoring has a sensitivity rate of
80-85%. To increase the sensitivity, we could also use
an index of esophageal symptoms such as pyrosis and
regurgitation.19 The algorithm as shown in Figure 1 could
be used as guidance for the evaluation of chest pain.
Up to now, the “therapeutic trial” test using high doses
of Proton Pump Inhibitors twice daily has been used.
This is a sensitive, effective and cheap test to differenti-
ate GERD from non-cardiac chest pain.20 This study used
40 mg of  omeprazole in the morning and 20 mg at night
for 7 days.
Respiratory tract disturbance
The cough reflex is induced by stimuli on the epithe-
lial sensory nerve (cough receptor) on the tracheobron-
chial or laryngeal reflex branch complex transmitted to
afferent nerves at the cough center in the brain stem,
followed by stimulation of efferent nerves in the dia-
phragm, larynx, abdominal muscles and thorax to pro-
duce cough. GERD could also directly cause chronic
cough due to stimulan of receptors in the trachea, lar-
ynx, and bronchus by aspiration fluid. It could also go
through the esophagobronchial reflex, due to exposure
of the acid-sensitive sensory nerves by reflux material.
The vagal and superior laryngeal nerve receptor path-
way could induce cough when stimulated by respiratory
tract secretion, foreign bodies, or tumor. 21 Increased
sensitivity of cough receptors could reduce the cough
threshold. Such mechanism occurs if angiotensin enzyme
inhibitors are used.22
GERD has been concluded to be able to cause chronic
cough in 10-20% of patients. GERD is the third cause of
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Figure 2. The algorithm of the evaluation of recurrent chest pain
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chronic cough after asthma and post nasal drip.23, 24 While
Ludviksdottir found a strongly positive correlation (odds
ratio = 4.4) between GERD and productive chronic
cough.25
The pathogenesis of GERD causes asthma includes
mechanosensitive (acid) afferent nerve fibers in the
esophagus. In some patients, a little acid could induce
bronchial spasm. GERD was found in approximately 30-
90% of asthmatic patients, but a cause and effect corre-
lation has yet to be proven.26
El Erag and Sonnenberg conducted a case-control
study to find the correlation between asthma and esoph-
agitis, resulting in an odds ratio of 1.51 (95% Cl, 1.43 to
1.59).27 This data illustrate the close relationship between
asthma and GERD.
Harding found a strong relationship between asthma
and esophageal disturbances in the form of heartburn,
regurgitation, nausea and acidic esophagus. Out of 55
asthmatic patients, 35 (64%) reported GERD symptoms,
while 58 (98%) of 59 patients with chronic cough was
found with GERD. In general, 119 out of 151 (78.8%)
patients with respiratory tract disturbances demonstrated
a relationship with esophageal acidity.28
Many studies have been conducted to evaluate the
effect of anti-reflux therapy. From 1966 to 1999 there
were 12 studies, involving 326 patients, 70% of which
demonstrated improved symptoms, 62% demonstrated
reduced use of asthmatic medications, and 26% demon-
strated lung function improvements.29
Otolaryngeal disturbance
The development laryngeal manifestation in GERD
are caused by the formation of singer’s node, laryngitis,
hoarseness, subglotic stenosis, and laryngeal malignancy.
These are cause by continuous gastroesophageal reflux
at night. 30
The upper esophageal sphincter pressure is reduced
at night, probably giving way for the reflux fluid to pass
freely, while defense mechanisms and neutralizing agents
such as saliva and cough are suppressed. The reflux
material then adheres to the larynx, pharynx, or oral epithel,
causing edema, inflammation and ulcer. These patho-
logic changes causes the disease as mentioned.30
GERD is the chief contribution trigger factor for
asthma, as well as many complaints of the ears, nose,
and throat. For example, over 80% of GERD patients
suffer from difficult to manage hoarseness, while 25 to
50% of GERD patients feel the presence of a mass, and
several suffer from laryngeal cancer. Clinical suspicion
is the key to the diagnosis, since many patients do not
complain of classic symptoms of pyrosis and regurgita-
tion. Monitoring of the pH level of the lower and upper
esophagus, pharynx, and larynx, is very helpful for es-
tablishing the diagnosis. Suppression of acid secretion
using medications as well as surgical therapy would cure
and aid these patients.31 El-Seraq HB evaluated 101.366
cases of esophagitis and esophageal stricture to deter-
mine a relationship, and compared it with the incidence
of sinusitis (Odds ratio 1.6 (1.51-1.7); Cl 95%), laryngi-
tis (OD 2.01; 1.53-2.63), pharyngitis (1.48; 1.15-1.89),
aphonia (1.81-2.80), laryngeal stenosis (2.02; 1.12-3.65),
chronic bronchitis (1.28; 1.22-1.34), asthma (1.51; 1.43-
1.59), chronic obstructive pulmonary disease (1.22; 1.16-
1.27), lung fibrosis (1.36; 1.43-1.59), bronchiectasis (1.26;
1.09-1.47), and pneumonia (1.15; 1.12-1.18). We could
thus conclude that GERD is a risk factor for disease of
the sinus, larynx, pharynx, and lungs.32
Management
The physiological stimulus for gastric acid secretion
is food. The secretion process is divided into three
phases; the cephalic, gastric, and intestinal phases. Basal
gastric acid secretion has a circadian variation, being
high at night and low in the morning.33
A step by step approach in the management of GERD
patients has been long been the rule. Initial therapy is
commenced by a simple therapeutic approach. GERD
management include life-style modification, avoidance
of meals before bedtime, and elevating the head during
sleep. Pharmacological intervention takes the form of
administration of antacids, H2-receptor antagonists
(H2Ras), prokinetic agents, and proton pump inhibitors.
Surgical intervention may be taken for recurrent GERD,
but such cases are rare.34
In the year 1987, Kruse-Anderson evaluated the
acidity of GERD patients, and found reflux for 6 hours
at night. Out of normal patients, 5.5% were found with
reflux, while 37.9% of GERD patients were found with
reflux. Esophageal motility of all patients were reduced
at night.35 Sozzi reported reduced gastric acid pH below
2 at night (from 11 pm to  am).36
Gastric acid secretion is influenced by several fac-
tors, including histamine, acetylcholine, and gastrin. Gas-
trin acid production generally depends on proton pumps,
influenced by the enzyme H+/K+ ATPase. Enzyme inhi-
bition at the proton pumps using proton-pump inhibitor
agents would not totally eliminate gastric acidity for 24
hours, even when administered day and night.37
Robinson compared the therapeutic effect of the ad-
ministration of 20 mg of omeprazole in the morning and
at night before bed (OME/OME) to the administration
of 20 mg of omeprazole in the morning and 75 mg of
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ranitidine at night before bed (OME/RAN). A reduction
of acid release at night was found in 68.75% of the
(OME/RAN) group and in 87.5% of the (OME/OME)
group.38
Meier reported 4 out of 15 (27%) of asthmatic pa-
tients with GERD who demonstrated improved lung func-
tion (FEV1 more than or equal to 20%) after adminis-
tration of 20 mg of omeprazole daily for six weeks.39
In GERD patients with extra-esophageal symptoms,
Peghini recommends initial therapy using proton pump
inhibitors twice daily (omeprazole 40-80 mg or
lansoprazole 60-120 mg daily) for 3 months until symp-
toms subsided. It would be even better to administer H2
inhibitors to prevent night-time acid release.40, 41
CONCLUSION
1. Gastroesophageal Reflux Disease (GERD) could
cause or trigger non-cardiac chest pain, respiratory
tract disturbances, as well as otolaryngeal distur-
bances.
2. The pathophysiological of GERD is through 2 chief
mechanisms, through the presence of gastroesoph-
ageal reflux with or without aspiration, and through
the stimulation of the esophagopulmonary reflex.
3. GERD manifestations could take the form of non-
cardiac chest pain, asthma, chronic bronchitis, lar-
yngitis, hoarseness, lung fibrosis, and malignancy.
4. Management is the same as general therapy for
GERD, and is emphasized on the use of high doses
of proton pump inhibitors and H2 inhibitors at night.
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